Skip to content

Author

E. Stieglitz

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Venetoclax as Salvage Treatment for Relapsed/Refractory B-ALL Post-CAR-T Therapy.

BACKGROUND Despite high early response rates following chimeric antigen receptor T-cell therapy (CAR-T) for relapsed/refractory pediatric B-cell acute lymphoblastic leukemia (B-ALL), many patients relapse, and downregulation of the antigen targeted by the CAR-T has emerged as a major challenge. Furthermore, minimal res...

Elizabeth E. Dong, Deborah E. Schiff, J. Rossoff et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.